{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1178.2",
  "meta": {
    "versionId": "9",
    "lastUpdated": "2021-04-06T01:00:19.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2",
  "version": "20210406",
  "name": "PCSK9 Inhibitors",
  "status": "active",
  "date": "2021-04-06T01:00:19-04:00",
  "publisher": "AHA Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "1659156",
            "display": "1 ML alirocumab 150 MG/ML Auto-Injector"
          },
          {
            "code": "1659165",
            "display": "1 ML alirocumab 150 MG/ML Prefilled Syringe"
          },
          {
            "code": "1659177",
            "display": "1 ML alirocumab 75 MG/ML Prefilled Syringe"
          },
          {
            "code": "1659182",
            "display": "1 ML alirocumab 75 MG/ML Auto-Injector"
          },
          {
            "code": "1665895",
            "display": "1 ML evolocumab 140 MG/ML Auto-Injector"
          },
          {
            "code": "1665904",
            "display": "1 ML evolocumab 140 MG/ML Prefilled Syringe"
          },
          {
            "code": "1801319",
            "display": "3.5 ML evolocumab 120 MG/ML Cartridge"
          }
        ]
      }
    ]
  }
}